October 2010

Possible Fracture Risk with Osteoporosis Drugs

For the past few years there has been a push by pharmaceutical companies to get women to take drugs to counteract the effects of osteoporosis. It sounds like a good idea–osteoporosis is a condition in which bones become more brittle, and are therefore more likely to fracture. Preventing fractures is a good thing, right? Sure. […]

Possible Fracture Risk with Osteoporosis Drugs Read More »

World Trade Center Attorneys Successful in Negotiating Liens on Settlement Proceeds

Victims of 9/11 have received settlement proceeds.  However, those settlement proceeds are subject to liens placed upon them by Worker’s Compensation Carriers.  The attorneys representing the victims of 9/11 have been successful in negotiating either a complete waiver of the lien or a substantial reduction in most cases. This is a fantastic example of attorneys

World Trade Center Attorneys Successful in Negotiating Liens on Settlement Proceeds Read More »

Obesity Drug Meridia Withdrawn from Market

The U.S. Food and Drug Administration (FDA) announced today that Abbott Laboratories has agreed to voluntarily withdraw its obesity drug Meridia (sibutramine) because scientific research has shown that the drug increases the risk of heart attack and stroke. According to John Jenkins, MD, director of the Office of New Drugs in the FDA’s Center for

Obesity Drug Meridia Withdrawn from Market Read More »

Scroll to Top